Baseline assessment | Follow-up assessment 1 (at end of intervention or after 9 months) | Follow-up assessment 2 (6 months after end of intervention or 9 month assessment) | |
---|---|---|---|
Participants | |||
Patient information and informed consent | X | ||
Demographics | X | ||
EQ-5D-5L | X | X | X |
ReQOL | X | X | X |
Patient activation measure | X | X | X |
Multimorbidity Treatment Burden Questionnaire | X | X | X |
De Jong Gierveld Loneliness Scale | X | X | X |
Participant goals | X | X | X |
Health Questionnaire including number of health screenings and service use in last 6 months | X | X | X |
Acceptability 1. Acceptability of intervention measure 2. Interview | X | ||
Appropriateness 1. Intervention appropriateness measure 2. Interview | X | ||
Feasibility 1. Feasibility of intervention measure 2. Interview | X | ||
Fidelity-interview | X | ||
Barriers and facilitators-interview | X | ||
Adoption-interview | X | X | |
Sustainability- Interview | X | X | |
Unintended consequences-interview | X | X | |
Experience of the intervention-interview | X | ||
Health champions | |||
Acceptability 1. Acceptability of intervention measure 2. Interview | X | ||
Appropriateness 1. Intervention appropriateness measure 2. Interview | X | ||
Feasibility 1. Feasibility of intervention measure 2. Interview | X | ||
Fidelity-interview | X | ||
Barriers and facilitators-interview | X | ||
Unintended consequences-interview | X | ||
Experience of the intervention-interview | X |